(Reuters) - "It was expected that a ruling was coming, but I didn't expect them to cut it to the price of a generic," said LeCroy.
While Medicare did not specify the size of the price cut, only placing it in the same code as a generic drug called albuterol, LeCroy said he expected the drop to be as much as 70 to 80 percent and affect about 15 percent of Xopenex sales.
Read more at Reuters.com Hot Stocks News
While Medicare did not specify the size of the price cut, only placing it in the same code as a generic drug called albuterol, LeCroy said he expected the drop to be as much as 70 to 80 percent and affect about 15 percent of Xopenex sales.
Read more at Reuters.com Hot Stocks News
No comments:
Post a Comment